Crossmark

Cost effectiveness and affordability of trastuzumab in sub-Saharan Africa for early stage HER2-positive breast cancer

Crossref DOI link: https://doi.org/10.1186/s12962-019-0174-7

Published Online: 2019-02-28

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gershon, Noga https://orcid.org/0000-0001-8621-5181
Berchenko, Yakir

Hall, Peter S.

Goldstein, Daniel A.
License Information

Text and Data Mining valid from 2019-02-28
More Information

Article History

Received: 16 July 2018

Accepted: 19 February 2019

First Online: 28 February 2019